Mutation in the transthyretin (TTR) gene may clinically manifest as cardiomyopathy. Here, we describe 69-year-old and 72-year-old brothers who were diagnosed as having TTR-related familial amyloid cardiomyopathy by endomyocardial biopsy at different hospitals at around the same time. They were not from an endemic area of familial amyloid polyneuropathy. Genetic analysis showed a base change in the TTR gene leading to a p.Val30Met mutation in both patients. Screening of family members, as well as detailed family history taking, is important for the diagnosis of cardiomyopathy of unknown etiology. © 2012 The Japanese Society of Internal Medicine.
CITATION STYLE
Miyamura, M., Terasaki, F., Ishibashi, K., Shimazaki, C., Kimura, F., Kuwabara, H., … Ishizaka, N. (2012). Two siblings diagnosed to have transthyretin-related familial amyloid cardiomyopathy around the same time at different hospitals. Internal Medicine, 51(5), 465–469. https://doi.org/10.2169/internalmedicine.51.6369
Mendeley helps you to discover research relevant for your work.